Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease
Completed
New Haven Pharmaceuticals, Inc.
Phase 1
2015-02-01
This study is being conducted to evaluate the safety and the length of effect on platelet
build-up in the arteries of Durlaza™ as compared to immediate-release Bayer® aspirin 81 mg or
subject's current aspirin 81 mg of choice in patients who have Type 2 diabetes mellitus and
cardiovascular disease or multiple risk factors of developing cardiovascular disease.
Study of Aspirin in Patients With Vestibular Schwannoma
Recruiting
Massachusetts General Hospital
Phase 2
2018-06-11
This is a phase II prospective, randomized, double-blind, longitudinal study evaluating
whether the administration of aspirin can delay or slow tumor growth and maintain or improve
hearing in VS patients.
Study of Aspirin in Patients With Vestibular Schwannoma
Recruiting
United States Department of Defense
Phase 2
2018-06-11
This is a phase II prospective, randomized, double-blind, longitudinal study evaluating
whether the administration of aspirin can delay or slow tumor growth and maintain or improve
hearing in VS patients.
Study of Aspirin in Patients With Vestibular Schwannoma
Recruiting
Massachusetts Eye and Ear Infirmary
Phase 2
2018-06-11
This is a phase II prospective, randomized, double-blind, longitudinal study evaluating
whether the administration of aspirin can delay or slow tumor growth and maintain or improve
hearing in VS patients.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
